Opportunity
Simpler Grants.gov #RFA-HL-26-019
NIH Solicitation for Medical Device Prototype Design, Disease Target Identification, and Assay Development
Buyer
National Institutes of Health
Posted
November 22, 2024
Respond By
December 23, 2027
Identifier
RFA-HL-26-019
NAICS
541715, 541714
The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is seeking proposals for the Catalyze Product Definition Program to advance early-stage translational research in medical devices and diagnostics. - Government Buyer: - National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI) - Products/Services Requested: - Medical device prototype design and testing - Disease target identification - Assay development and research tool piloting - Two-phase structure: - R61: Initial prototype testing, research tool piloting - R33: Continued prototype development, diagnostic product generation, assay exploration - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Unique/Notable Requirements: - Open to a broad range of applicants: nonprofits, educational institutions, government entities, businesses, and certain foreign organizations - Focus on advancing projects toward readiness for in vivo testing - Complements other NIH translational research initiatives - No specific products, part numbers, or purchase quantities listed
Description
The NHLBI Catalyze Program supports the transition of basic science discoveries into diagnostic and therapeutic candidates ready for human testing. It focuses on early-stage projects involving device prototypes, disease target identification, assay development, and related research tools. The program has two phases: R61 for initial prototype testing and research tool piloting, and R33 for continued prototype development and diagnostic product generation. Successful projects are expected to advance toward in vivo testing with additional NIH or private support. The initiative complements other related programs and is open to a wide range of eligible applicants including nonprofits, educational institutions, government entities, and businesses.